ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2018

Microenvironment Driven Re-Shaping of Pathogenic T Effector and Regulatory Subset in Active Juvenile Idiopathic Arthritic Patients

Jing Yao Leong1, Pavanish Kumar1, Phyllis Chen2, Joo Guan Yeo2,3, Camillus Chua2, Sharifah Nur Hazirah2, Suzan Saidin1, Thaschawee Arkachaisri2,3, Alessandro Consolaro4, Marco Gattorno5, Alberto Martini6 and Salvatore Albani2, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 3KK Women's and Children's Hospital, Singapore, Singapore, 4Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genova, Italy, 5Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genoa, Italy, 6Pediatric Rheumatology International Trial Organization (PRINTO) Coordinating Centre, Genoa, Italy

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), pathogenesis and transcriptional regulation, RNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

We have previously identified two CD4 pathogenic circulatory subsets in both T effector (CPLs) and T regulatory (iaTreg) compartments that are both HLA-DR+, antigen experienced, pro-inflammatory, correlating with disease activity and sharing strong TCR sequence oligoclonality with synovial T cells from JIA patients. Despite being two functionally distinct T cell subsets, their phenotype and association with clinical fate suggests that these functionally discordant subsets may originate from a common precursor. To elucidate the common pathogenic gene drivers and their associated network of pathways within these two pathogenic subsets, we decided to perform next generation RNA sequencing on sorted CPLs and iaTregs and their conventional Teff/Treg counterparts in both the circulation and the synovial micro-environment.

Methods:

CPLs were sorted as CD3+ CD4+ CD14– HLADR+ CD25/CD127 Teff gate, and iaTregs were sorted as CD3+ CD4+ CD14– HLADR+ CD25hi/CD127low Treg gate with FACs Aria II from n=16 active JIA PBMCs, n=8 paired JIA SFMCs, and n=8 healthy paediatric PBMCs. As a comparative control, similar HLADR– counterparts were respectively sorted from the same patients. Sorted cells were lysed and extracted for RNA, and cDNA conversion/amplification were then carried out using SMART-seq v4. Libraries are prepared and multiplexed using Nextera XT DNA library preparation kit, and ran on the Illumina HiSeq High output platform.

Results:

Comparative differential gene expression (DEG) reveal strong transcriptomic convergence between CPLs and iaTregs as compared with the common pool of Teff and Treg. Phylogenetic analysis indicate the convergence has uncoupled the CPLs or the iaTregs away from their respective original compartments (Teff or Treg) into a common branch point. Restriction in TCR sequence oligoclonality in CPLs/iaTregs versus that of the common Teff/Treg pool reinforce the possibility of a common selection pressure. Pathway enrichment analysis reveal similar dysregulated pathways (IFN-g, PD1, CD28 costimulation) within T cell signalling for both CPLs and iaTregs. Furthermore, Weighted gene correlation network analysis (WGCNA) identified strongly coordinated HLA-DR gene network module and suggests its potential role as the driver of pathogenic T cell subsets away from conventional subsets. Gene set enrichment analysis (GESA) suggest that HLA-DR module genes are involved in TNFA signalling, inflammatory response, complement, and apoptosis. Global transcription factors gene regulatory network (TF-GRN) analysis identified several key regulatory molecules (FOXP3, CEBP, SPI and E2F1) driving the convergence of pathogenic CPLs and iaTreg populations. Taken together , we have shown that reveal several layers of mechanism operate to drive the convergence of CPLs and iaTregs, suggesting the possibility of common disease drivers in active JIA patients.

Conclusion:

Overall the transcriptomic data indicate strong similarity in both pathogenic populations and underscore a potential mechanistic role of the inflammatory microenvironment in shaping two functionally dichotomic populations.


Disclosure: J. Y. Leong, None; P. Kumar, None; P. Chen, None; J. G. Yeo, None; C. Chua, None; S. Nur Hazirah, None; S. Saidin, None; T. Arkachaisri, None; A. Consolaro, None; M. Gattorno, None; A. Martini, None; S. Albani, None.

To cite this abstract in AMA style:

Leong JY, Kumar P, Chen P, Yeo JG, Chua C, Nur Hazirah S, Saidin S, Arkachaisri T, Consolaro A, Gattorno M, Martini A, Albani S. Microenvironment Driven Re-Shaping of Pathogenic T Effector and Regulatory Subset in Active Juvenile Idiopathic Arthritic Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/microenvironment-driven-re-shaping-of-pathogenic-t-effector-and-regulatory-subset-in-active-juvenile-idiopathic-arthritic-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microenvironment-driven-re-shaping-of-pathogenic-t-effector-and-regulatory-subset-in-active-juvenile-idiopathic-arthritic-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology